Traditional Biomarkers And Pancreatic Cancer: There Is Still A Role In The Molecular Era?
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S407
DOI: 10.1055/s-0044-1783715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. G. Demarzo und 5 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Aims
As known, the overall survival and the prognosis of patients with pancreatic cancer (PC) remain poor as most of the cases are diagnosed at advanced stages due to the lack of specific symptoms and biomarkers.Serum carbohydrate antigen 19-9 (Ca19-9) is used to monitor response to treatment and identify patients with poor prognosis, but its value as a screening or early diagnostic tool remains controversial. New blood-based biomarkers such as cell-free DNA, exosomes, and circulating tumor cells are currently being investigated for monitoring response to treatment but they are far from be included in clinical practice.The aim of our study is to evaluate the role of traditional serum biomarkers in the management of PC patients staged by both Computed tomography (CT) and Endoscopic ultrasound (EUS).
Methods
Medical records of 36 patients with a radiologically and endoscopic proven mass in the head/uncinate process of the pancreas were retrospectively reviewed.We considered tumor size, tumor stage (according to the TNM system) and serum biomarkers measured before any biliary drainage: direct bilirubin, aminotransferases, γ-glutamyltransferase (GGT),alkaline phosphatase (ALP) and Ca19-9 levels.To analyze the relationship of biomarkers serum concentrations with tumor stage the Kruskall Wallis test was used. Spearman’s rank correlation coefficient was used to assess the association between tumor size and both Ca19.9 and direct bilirubin levels. We investigated the agreement between CT and Endoscopic Ultrasound EUS using the Bland Altman plot analysis.
Results
Among 36 cases of PC, 5 were staged as stage I, 11 as stage II, 11 as stage III and 9 as stage IV. Tumor stage was significantly associated to GGT (p
Zitieren
APA
Demarzo, M. G., Mossa, M., Marrone, C., Assandri, L., Mazza, F., & Parodi, M. C. (2024). Traditional Biomarkers And Pancreatic Cancer: There Is Still A Role In The Molecular Era?. Endoscopy, 56(S 02 S 02), S407. https://doi.org/10.1055/s-0044-1783715
Vancouver
Demarzo MG, Mossa M, Marrone C, Assandri L, Mazza F, Parodi MC. Traditional Biomarkers And Pancreatic Cancer: There Is Still A Role In The Molecular Era?. Endoscopy. 2024;56(S 02 S 02):S407. doi:10.1055/s-0044-1783715
BibTeX
@article{Demarzo2024,
author = {Demarzo, M. G. and Mossa, M. and Marrone, C. and Assandri, L. and Mazza, F. and Parodi, M. C.},
title = {Traditional Biomarkers And Pancreatic Cancer: There Is Still A Role In The Molecular Era?},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S407},
doi = {10.1055/s-0044-1783715}
}
EUVIMED